Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Arginine
11%
ATPase
31%
Calcium Signaling
9%
Cancer Cell
13%
Cardiac Muscle Cell
100%
Cell Membrane
19%
CGMP-dependent Protein Kinase
69%
Cyclic Guanosine Monophosphate
62%
Cysteine
28%
Deficiency
11%
Disulfide Bond
12%
Gene Deletion
15%
Gene Expression
11%
Glycoprotein
14%
Heart Ejection Fraction
21%
Heart Function
35%
In Vitro Study
10%
Isoform
13%
Kinase
10%
Mammalian Target of Rapamycin Complex 1
19%
Maturation
28%
Mechanical Stress
11%
Messenger RNA
10%
MicroRNA
9%
Muscle Contractility
25%
Natriuretic Peptide
25%
Neutrophil Chemotaxis
9%
Nitric Oxide
17%
Nitric Oxide Synthase
23%
Osteopontin
9%
Oxidative Stress
20%
Peroxisome Proliferator-Activated Receptor
12%
Phenylephrine
10%
Phosphodiesterase
71%
Phospholamban
28%
phosphorylation
25%
Phosphotransferase
10%
Programmed Cell Death
12%
Protein Kinases
19%
Rat
20%
Receptor Potential
11%
Reperfusion
19%
Serine
10%
Stem Cell
12%
Thiol
13%
Thrombospondin
10%
TRPC3
13%
TRPC6
19%
Upregulation
14%
Vasodilatation
13%
Keyphrases
Ca2+
21%
Ca2+-ATPase
13%
Cardiac Function
13%
Cardiac Hypertrophy
11%
Cardiac Ischemia/reperfusion Injury
12%
Cardiac muscle
19%
Cardiac Remodeling
12%
Cardiac Stress
15%
Cardiomyocytes
25%
Cardiomyopathy
12%
Cardioprotection
11%
Contractility
12%
Cyclic GMP
44%
Cysteine
24%
Docetaxel
12%
DU145
11%
Heart Disease
23%
Heart Failure
39%
Heart Failure with Preserved Ejection Fraction (HFpEF)
21%
Human Prostate Cancer Cells
19%
Hyperactivity
12%
Hypertrophy
16%
Ischemia-reperfusion
12%
Mammalian Target of Rapamycin (mTOR)
19%
Mitochondrial Pathway
12%
Mucin
15%
Mucin 1 (MUC1)
13%
Myocytes
39%
Nitroxyl
20%
Oxidative Stress
14%
Pathological Cardiac Hypertrophy
19%
Phosphodiesterase
19%
Phosphodiesterase 9 (PDE9)
17%
Phosphodiesterase Type 5 Inhibitors
25%
Phospholamban
28%
Phosphorylation
28%
Plasma Membrane
14%
Pressure Overload
17%
Prostate Cancer
12%
Protein Kinase
16%
Protein Kinase G
39%
Redox
19%
Sarcoplasmic Reticulum Ca2+-ATPase
14%
SERCA2a
32%
Sildenafil
13%
Specificity Protein 1
11%
Thapsigargin
30%
Thiols
13%
TRPC6
14%
Tuberous Sclerosis Complex
12%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
9%
Adenosine Triphosphatase (Calcium)
9%
Calcium Ion
17%
Catenin
9%
Congestive Heart Failure
30%
Connexin 43
9%
Curcumin
9%
Cyclic GMP
50%
Cyclic GMP Dependent Protein Kinase
30%
Cysteine
19%
Cytoprotective Agent
9%
Diseases
21%
Docetaxel
12%
Dog
9%
Endothelial Nitric Oxide Synthase
9%
Estrogen
9%
Heart Disease
29%
Heart Failure with Preserved Ejection Fraction
20%
Heart Infarction
9%
Heart Muscle Fibrosis
10%
Heart Ventricle Hypertrophy
29%
Heart Ventricle Remodeling
13%
Left Ventricular Diastolic Dysfunction
9%
Leporidae
9%
Mammalian Target of Rapamycin Complex 1
9%
Marfan Syndrome
9%
microRNA
9%
Minipig
9%
Mitogen Activated Protein Kinase 3
9%
Molecular Target
9%
Myocardial Disease
24%
Nanoparticle
9%
Natriuretic Factor
11%
Neoplasm
12%
Neuroendocrine Carcinoma
9%
Osteopontin
9%
Phosphodiesterase
21%
Phosphodiesterase V
44%
Phosphodiesterase V Inhibitor
12%
Phospholamban
19%
Prostate Cancer
11%
Protein Kinases
9%
Rat
11%
Receptor
15%
Saxagliptin
9%
SCID Mouse
9%
Sildenafil
13%
Tadalafil
9%
Thapsigargin
9%
Thiol
12%